Paul Colvin

President, Clinical Solutions
  • Responsible for driving growth and performance for the Company’s industry-leading Clinical Solutions capabilities, delivering Full Service, FSP and Hybrid models; also drives therapeutic alignment and delivery of the Trusted Process®
  • Two decades of experience in global clinical development in the CRO and biopharmaceutical industries
  • Most recently served as Executive Vice President, Biopharma Partnerships and Chairman and CEO of PPD-SNBL, a joint venture that has grown to be one of the largest clinical development service providers in Japan
  • Spent nearly 15 years at Eli Lilly and Company in a variety of increasingly significant roles gaining global, operational and patient enrollment experience across multiple therapeutic areas – roles included Head of Clinical Operations and Global Patient Enrollment Optimization, Chief Operations Officer of the Cardiovascular Global Brand team, Head of European Clinical Operations and Head of Global Clinical Operations for the Oncology Product team
  • Bachelor of Science in Pharmacy, Butler University; Registered Pharmacist; Completed executive development programs at London Business School and the Center for Creative Leadership